- Report
- July 2024
- 100 Pages
Global
From €3327EUR$3,750USD£2,880GBP
- Report
- July 2024
- 150 Pages
Global
From €3327EUR$3,750USD£2,880GBP
- Report
- July 2024
- 150 Pages
Global
From €3327EUR$3,750USD£2,880GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3327EUR$3,750USD£2,880GBP
- Report
- February 2024
- 112 Pages
Global
From €4215EUR$4,750USD£3,649GBP
- Report
- February 2024
- 115 Pages
Global
From €4215EUR$4,750USD£3,649GBP
- Report
- February 2024
- 120 Pages
Global
From €4215EUR$4,750USD£3,649GBP
- Report
- February 2024
- 100 Pages
Japan
From €4215EUR$4,750USD£3,649GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4215EUR$4,750USD£3,649GBP
- Report
- April 2023
- 111 Pages
Global
From €4215EUR$4,750USD£3,649GBP
- Report
- April 2023
- 112 Pages
Global
From €4215EUR$4,750USD£3,649GBP
- Report
- July 2021
- 115 Pages
Global
From €4215EUR$4,750USD£3,649GBP
- Report
- December 2022
- 79 Pages
North America
From €1331EUR$1,500USD£1,152GBP
- Report
- December 2024
- 140 Pages
Global
From €3505EUR$3,950USD£3,034GBP
- Report
- March 2024
- 124 Pages
Global
From €3771EUR$4,250USD£3,265GBP
- Report
- February 2024
- 141 Pages
Global
From €3771EUR$4,250USD£3,265GBP
- Report
- January 2024
- 110 Pages
Global
From €3993EUR$4,500USD£3,457GBP
- Report
- June 2024
- 140 Pages
Europe
From €4391EUR$4,949USD£3,801GBP
- Report
- February 2024
- 160 Pages
Africa
From €3433EUR$3,869USD£2,972GBP
- Report
- May 2023
- 147 Pages
Global
From €4391EUR$4,949USD£3,801GBP

The Family Planning market is an important part of Women's Health, providing access to contraception and other reproductive health services. It is a diverse market, with a range of products and services available to meet the needs of women of all ages. These include hormonal contraceptives, such as the pill and the patch, as well as long-acting reversible contraceptives, such as intrauterine devices and implants. Other services include counseling, education, and access to emergency contraception.
Family Planning services are essential for women to make informed decisions about their reproductive health, and to ensure that they have access to the resources they need to make those decisions. It is also important for reducing unintended pregnancies and promoting healthy pregnancies.
Some companies in the Family Planning market include Bayer, Merck, Pfizer, and Allergan. Show Less Read more